PAR
Click for more information
2.63% 19.5¢ paradigm biopharmaceuticals limited..

Pfizer's Tanezumab receives almost unanimous rejection by FDA Adcom, page-21

  1. edski1
    1,226 Posts.
    lightbulb Created with Sketch. 177
    clock Created with Sketch.
    29/03/21
    10:36
    Post #: 52106183
    Thanks jcurve.
    PAR Price at posting: $2.68 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢ 		Change
0.005(2.63%) 		Mkt cap ! $68.29M
Open High Low Value Volume
20.0¢ 21.0¢ 19.0¢ $321.4K 1.618M

Buyers (Bids)

No. Vol. Price($)
3 90000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 16216 1
View Market Depth
Last trade - 16.10pm 30/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.